Adma Biologics: 3Q Earnings Snapshot

Associated Press |

RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $15.1 million in its third quarter.

On a per-share basis, the Ramsey, New Jersey-based company said it had a loss of 33 cents.

The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 33 cents per share.

The infectious disease drug developer posted revenue of $4.2 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $5.4 million.

Adma Biologics shares have climbed 79 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $5.74, more than doubling in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

MGX Minerals Inc.

MGX Minerals is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that…